NCT01767571View on ClinicalTrials.gov

Bioequivalence Study of Cephalexin Suspension 250

PHASE1CompletedINTERVENTIONAL

Enrollment

28

Participants

Timeline

Start Date

January 30, 2011

Primary Completion Date

February 8, 2011

Study Completion Date

February 8, 2011

Conditions

Infections, Respiratory Tract

Interventions

DRUG

Cephalexin 125 mg/5ml

Reference product 20 ml

DRUG

Cephalexin 250mg/5ml

Test product 10 ml

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT01767571 - Bioequivalence Study of Cephalexin Suspension 250 | Biotech Hunter | Biotech Hunter